Daniel-Adriano Silva

Daniel-Adriano Silva

Auto-generated profile, based on publicly available information

Daniel-Adriano Silva

Department of Biochemistry and Institute for Protein Design, University of Washington, Seattle, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
DSDaniel-Adriano Silva
Daniel-Adriano Silva
SYShawn Yu
Shawn Yu
UUUmut Y. Ulge
Umut Y. Ulge
JSJamie B. Spangler
Jamie B. Spangler
KJKevin M. Jude
Kevin M. Jude
DBDavid Baker
David Baker

16 December 2011 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YHYuning Hong
Yuning Hong
LMLuming Meng
Luming Meng
SCSijie Chen
Sijie Chen
CLChris Wai Tung Leung
Chris Wai Tung Leung
LDLintai Da
Lintai Da
BTBen Zhong Tang
Ben Zhong Tang

26 May 2011 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
DSDaniel-Adriano Silva
Daniel-Adriano Silva
GBGregory R. Bowman
Gregory R. Bowman
ASAlejandro Sosa-Peinado
Alejandro Sosa-Peinado
XHXuhui Huang
Xuhui Huang
Molecular recognition is determined by the structure and dynamics of both a protein and its ligand, but it is difficult to directly assess the role of each of these players. In this study, we use Markov State Models (MSMs) built from atomistic simulations to elucidate the mechanism by which the Lysine-, Arginine-, Ornithine-binding (LAO) protein binds to its ligand. We show that our model can predict the bound state, binding free energy, and association rate with reasonable accuracy and then use the model to dissect the binding mechanism. In the past, this binding event has often been assumed to occur via an induced fit mechanism because the protein's binding site is completely closed in the bound state, making it impossible for the ligand to enter the binding site after the protein has adopted the closed conformation. More complex mechanisms have also been hypothesized, but these have remained controversial. Here, we are able to directly observe roles for both the conformational selection and induced fit mechanisms in LAO binding. First, the LAO protein tends to form a partially closed encounter complex via conformational selection (that is, the apo protein can sample this state), though the induced fit mechanism can also play a role here. Then, interactions with the ligand can induce a transition to the bound state. Based on these results, we propose that MSMs built from atomistic simulations may be a powerful way of dissecting ligand-binding mechanisms and may eventually facilitate a deeper understanding of allostery as well as the prediction of new protein-ligand interactions, an important step in drug discovery. Protein-ligand interactions are crucial to chemistry, biology and medicine. Many studies have been conducted to probe the mechanism of protein-ligand binding, leading to the development of the induced fit and conformational selection models. Unfortunately, experimentally probing the atomistic details of protein-ligand binding mechanisms is challenging. Computer simulations have the potential to provide a detailed picture of molecular recognition events. In this study, we construct kinetic network models from atomistic simulations to elucidate the mechanism by which the LAO protein binds to its ligand. Because the LAO protein completely encompasses its substrate in the bound state, it has generally been assumed that it operates via an induced fit mechanism. We find that both the conformational selection and induced fit mechanisms play important roles in LAO binding. Furthermore, we have identified a number of parallel pathways for binding, all of which pass through a single gatekeeper state, which we refer to as the encounter complex state because the protein is partially closed and only weakly interacting with its substrate.

15 December 2017 in Science
Verified
Journal Article
Closed access
PDF file
PHParisa Hosseinzadeh
Parisa Hosseinzadeh
GBGaurav Bhardwaj
Gaurav Bhardwaj
VMVikram Khipple Mulligan
Vikram Khipple Mulligan
MSMatthew D. Shortridge
Matthew D. Shortridge
TCTimothy W. Craven
Timothy W. Craven
DBDavid Baker
David Baker
Macrocycles by design: Macrocyclic peptides have diverse properties, including antibiotic and anticancer activities. This makes them good therapeutic leads, but screening libraries only cover a fraction of the sequence space available to peptides comprising D and L amino acids. Hosseinzadeh et al. achieved near-complete coverage in sampling the sequence space for 7- to 10-residue cyclic peptides and identified more than 200 designs predicted to fold into stable structures. Of 12 structures determined, nine were close to the computational models. They also sampled and designed 11- to 14-residue macrocycles, but without complete coverage. The designed macrocycles provide a path forward for engineering new therapeutics. Science , this issue p. 1461

4 December 2020 in Science
Verified
Journal Article
Open access
PDF file
TLThomas W. Linsky
Thomas W. Linsky
RVRenan Vergara
Renan Vergara
NCNuria Codina
Nuria Codina
JNJorgen W. Nelson
Jorgen W. Nelson
MWMatthew J. Walker
Matthew J. Walker
DSDaniel-Adriano Silva
Daniel-Adriano Silva
A decoy to neutralize SARS-CoV-2: Many efforts to develop therapies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are focused on the interaction between the spike protein, which decorates the surface of the virus, and its host receptor, human angiotensin-converting enzyme 2 (hACE2). Linsky et al. describe a de novo design strategy that allowed them to engineer decoy proteins that bind to the spike protein by replicating the hACE2 interface. The best decoy, CTC-445, bound with low nanomolar affinity, and selection of viral mutants that decrease binding is unlikely because this would also affect binding to hACE2. A bivalent version of CTC-445 bound even more tightly, neutralized SARS-CoV-2 infection of cells, and protected hamsters from a SARS-CoV-2 challenge. The stable decoy has the potential for respiratory therapeutic delivery. Science , this issue p. 1208

21 April 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DSDaniel-Adriano Silva
Daniel-Adriano Silva
DWDahlia R. Weiss
Dahlia R. Weiss
FAFátima Pardo Avila
Fátima Pardo Avila
LDLintai Da
Lintai Da
MLMichael Levitt
Michael Levitt
XHXuhui Huang
Xuhui Huang
Significance: In this study, by using molecular dynamics simulations and Markov state models, we reveal that RNA polymerase II translocation is driven purely by thermal energy and does not require the input of any additional chemical energy. Our simulations show an important role for the bridge helix: Large thermal oscillations of this structural element facilitate the translocation by specific interactions that lower the free-energy barriers between four metastable states. Among these states, we identify two previously unidentified intermediates that have not been previously captured by crystallography. The dynamic view of translocation presented in our study represents a substantial advance over the current understanding based on the static snapshots provided by X-ray structures of transcribing complexes.